http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006032464-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e4ac33c8414d63b4c70093d9a86ccf2
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-30
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-30
filingDate 2005-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d12e3adef736f3e4c325d73a3aa89da0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c2730fb0aa8e22eed02eefc15fb7f37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0aece75a1dd2f76e2ef8d3f919016374
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe927c9a3fcb49f20f73288678cae2fb
publicationDate 2006-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2006032464-A2
titleOfInvention Method of treatment of acute exudative skin lesions and composition useful therefor
abstract The invention refers to the use of zinc oxide as unique pharmacologically active ingredient, in combination with a pharmaceutically acceptable hydrophilic vehicle, for the preparation of a pharmaceutical composition dedicated to the topical treatment of edges of chronic wounds and/or acute exudative skin lesions caused by intertrigo, decubitus, ulcus cruris, wet eczema, skin maceration, skin fissuring or skin photo damaging. The invention also provides a pharmaceutical composition comprising zinc oxide as unique pharmacologically active ingredient, in combination with a pharmaceutically acceptable hydrophilic vehicle.
priorityDate 2004-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6221403-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4512978-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03051378-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9959538-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445639
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393970
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559192
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID637517
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394900
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8042
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395574
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397123
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136301963
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16218600
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14806
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396196
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14455022
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397122
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5754
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393971
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2682

Total number of triples: 38.